E2E Deal Insights is a community where we delve into topics related to buying, selling, integrating, and separating a company.
Fresenius has evolved from a traditional German pharmacy into a disciplined serial acquirer in global healthcare. By balancing aggressive expansion with recent portfolio simplifications, the group demonstrates how to create long-term enterprise value through M&A. Can other capital-intensive industries successfully replicate their structural simplification playbook?
Keep reading
Fresenius has evolved from a traditional German pharmacy into a disciplined serial acquirer in global healthcare. By balancing aggressive expansion with recent portfolio simplifications, the group demonstrates how to create…
Data migration failures quietly derail millions of dollars in projected M&A synergies long after the deal ink dries. Discover why conducting rigorous data-migration readiness assessments upfront is the ultimate safeguard…
Navigating multi-jurisdictional M&A requires a rigorous evaluation of tax, legal, and operational constraints across asset deals, share deals, mergers, and hybrid structures. Experienced deal teams must balance competing jurisdictional demands…
Unmanaged employee turnover remains one of the primary reasons post-merger integrations fail to achieve target synergies. Implementing a retention-risk heatmap allows M&A practitioners to identify vulnerable high-value talent using predictive…
When you subscribe you become part of our community and you will be able to get access to our resources and get our exclusive newsletter delivered directly into your inbox.
